Scholars Central

Conference abstractPublished 14 Apr 2014

Serpins as therapy: From virus to man

Authors: Alexandra Lucas

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Serpins have critical regulatory roles in coagulation and inflammatory pathways. These ubiquitous regulators are present in organisms from viruses to horseshoe crabs and to mammals, representing a large percentage of circulating proteins in the blood. The impact of serpins on normal physiological function and homeostasis is evident in patients with genetic mutations that case severe disorders such as deficiency in alpha1 antitrypsin and neuroserpin and lethal sepsis with disseminated intravascular coagulation (DIC) where there is serpindys regulation. Modification of serpin activity is used for treating some clinical disorders, e.g. heparin is used to decrease clotting through activation of antithrombin (AT III) and AAT replacement which is given to patients with genetic deficiency and emphysema. Prior studies have also reported the use of N terminal serpin peptides for treatment in sepsis and HIV. Our research group has been examining virus-derived serpins as potential therapeutics. Prior work beginning with our original studies with the Myxomaviralserpin, Serp-1, have demonstrated significant reductions in vascular disease with Serp-1 treatment in models of arterial balloon angioplasty and in aortic, renal and cardiac transplants in rodent models. Serp-1 treatment improved mortality in lethal Mouse gamma herpes virus (MHV68) in interferon gamma receptor (IFNgR) knockout mice. and mouse adapted Zaire Ebola infection with associated reduced pulmonary hemorrhage, and congestion Serp-1 has also been tested in a phase 2A clinical trial after coronary stent implant with a demonstrated significant reduction in markers for myocardial damage, related work with mammalian serpins such as NSP have also demonstrated anti-inflammatory activity in animal models. In recent work we have assessed the capacity of Viral and mammalian serpin reactive center loop (RCL) peptides to expand serpin functions and to reduce inflammatory responses with significant reductions in plaque growth in a aortic transplant model. In conclusion, viral serpins have evolved over many millions of years to form highly efficient regulators of host central inflammatory pathways, identifying new therapeutic targets and potential function as anti-inflammatory protein drugs

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Alexandra Lucas”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels